At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biological target, shares the spotlight with an emerging and alternative polypharmacology approach. Polypharmacology suggests that more effective drugs can be developed by specifically modulating multiple targets. It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches. In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs. In this review, we will compare advantages and disadvantages of multitarget versus combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.

Polypharmacology: challenges and opportunities in drug discovery / Anighoro, Andrew; Bajorath, Jürgen; Rastelli, Giulio. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 57:19(2014), pp. 7874-7887. [10.1021/jm5006463]

Polypharmacology: challenges and opportunities in drug discovery

ANIGHORO, ANDREW;RASTELLI, Giulio
2014

Abstract

At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biological target, shares the spotlight with an emerging and alternative polypharmacology approach. Polypharmacology suggests that more effective drugs can be developed by specifically modulating multiple targets. It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches. In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs. In this review, we will compare advantages and disadvantages of multitarget versus combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.
2014
57
19
7874
7887
Polypharmacology: challenges and opportunities in drug discovery / Anighoro, Andrew; Bajorath, Jürgen; Rastelli, Giulio. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 57:19(2014), pp. 7874-7887. [10.1021/jm5006463]
Anighoro, Andrew; Bajorath, Jürgen; Rastelli, Giulio
File in questo prodotto:
File Dimensione Formato  
Polypharmacology_ChallengesOpportunities_2014_Rastelli.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 3.18 MB
Formato Adobe PDF
3.18 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1062374
Citazioni
  • ???jsp.display-item.citation.pmc??? 257
  • Scopus 755
  • ???jsp.display-item.citation.isi??? 703
social impact